Easotic 1.11 mg/ml + 1505 IU/ml + 15.1 mg/ml - Ear drops, suspension
Easotic 1.11 mg/ml + 1505 IU/ml + 15.1 mg/ml - Ear drops, suspension
Authorised
- Hydrocortisone aceponate
- Miconazole nitrate
- Gentamicin sulfate
Product identification
Medicine name:
Easotic 1.11 mg/ml + 1505 IU/ml + 15.1 mg/ml - Ear drops, suspension
Active substance:
- Hydrocortisone aceponate
- Miconazole nitrate
- Gentamicin sulfate
Target species:
-
Dog
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
Hydrocortisone aceponatePresentation_strength:1.11 mg Reference:Hse Index:0
-
Miconazole nitratePresentation_strength:15.1 mg Reference:Ph Eur Index:1
-
Gentamicin sulfatePresentation_strength:1505 IU Reference:Ph Eur Index:2
Pharmaceutical form:
-
Ear drops, suspension
Withdrawal period by route of administration:
-
Auricular use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Package description:
- Packaging:Pipette (HDPE), Package_size:200 pipettes, Content:1 ml
- Packaging:Pipette (HDPE), Package_size:100 pipettes, Content:1 ml
- Packaging:Pipette (HDPE), Package_size:50 pipettes, Content:1 ml
- Packaging:Pipette (HDPE), Package_size:10 pipettes, Content:1 ml
- Packaging:Pipette (HDPE), Package_size:5 pipettes, Content:1 ml
- Packaging:Container (PP), Package_size:1 container, Content:10 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- VIRBAC
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 6/03/2024
Bulgarian (PDF)
Published on: 6/03/2024
Croatian (PDF)
Published on: 6/03/2024
Czech (PDF)
Published on: 6/03/2024
Danish (PDF)
Published on: 6/03/2024
Dutch (PDF)
Published on: 6/03/2024
Estonian (PDF)
Published on: 6/03/2024
Finnish (PDF)
Published on: 6/03/2024
French (PDF)
Published on: 6/03/2024
German (PDF)
Published on: 6/03/2024
Greek (PDF)
Published on: 6/03/2024
Hungarian (PDF)
Published on: 6/03/2024
Icelandic (PDF)
Published on: 6/03/2024
Italian (PDF)
Published on: 6/03/2024
Latvian (PDF)
Published on: 6/03/2024
Lithuanian (PDF)
Published on: 6/03/2024
Maltese (PDF)
Published on: 6/03/2024
Norwegian (PDF)
Published on: 6/03/2024
Polish (PDF)
Published on: 6/03/2024
Portuguese (PDF)
Published on: 6/03/2024
Romanian (PDF)
Published on: 6/03/2024
Slovak (PDF)
Published on: 6/03/2024
Slovenian (PDF)
Published on: 6/03/2024
Spanish (PDF)
Published on: 6/03/2024
Swedish (PDF)
Published on: 6/03/2024
ema-puar-easotic-v-140-par-en.pdf
English (PDF)
Download Published on: 17/03/2023
How useful was this page?:
